357 related articles for article (PubMed ID: 24095750)
1. 2-(2-Hydrazinyl)thiazole derivatives: design, synthesis and in vitro antimycobacterial studies.
Makam P; Kankanala R; Prakash A; Kannan T
Eur J Med Chem; 2013 Nov; 69():564-76. PubMed ID: 24095750
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antimycobacterial activities of some new thiazolylhydrazone derivatives.
Ozadali K; Tan OU; Yogeeswari P; Dharmarajan S; Balkan A
Bioorg Med Chem Lett; 2014 Apr; 24(7):1695-7. PubMed ID: 24631185
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in silico antimalarial activity of 2-(2-hydrazinyl)thiazole derivatives.
Makam P; Thakur PK; Kannan T
Eur J Pharm Sci; 2014 Feb; 52():138-45. PubMed ID: 24231338
[TBL] [Abstract][Full Text] [Related]
4. Development of 5-nitrothiazole derivatives: identification of leads against both replicative and latent Mycobacterium tuberculosis.
Jeankumar VU; Chandran M; Samala G; Alvala M; Koushik PV; Yogeeswari P; Salina EG; Sriram D
Bioorg Med Chem Lett; 2012 Dec; 22(24):7414-7. PubMed ID: 23137434
[TBL] [Abstract][Full Text] [Related]
5. 2-Aminothiazole derivatives as antimycobacterial agents: Synthesis, characterization, in vitro and in silico studies.
Makam P; Kannan T
Eur J Med Chem; 2014 Nov; 87():643-56. PubMed ID: 25305331
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological evaluation of imidazo[2,1-b]thiazole and benzo[d]imidazo[2,1-b]thiazole derivatives as Mycobacterium tuberculosis pantothenate synthetase inhibitors.
Samala G; Devi PB; Saxena S; Meda N; Yogeeswari P; Sriram D
Bioorg Med Chem; 2016 Mar; 24(6):1298-307. PubMed ID: 26867485
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of substituted 4-arylthiazol-2-amino derivatives as potent growth inhibitors of replicating Mycobacterium tuberculosis H₃₇Rv.
Roy KK; Singh S; Sharma SK; Srivastava R; Chaturvedi V; Saxena AK
Bioorg Med Chem Lett; 2011 Sep; 21(18):5589-93. PubMed ID: 21783364
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of some novel 2-substituted-5-[isopropylthiazole] clubbed 1,2,4-triazole and 1,3,4-oxadiazoles as potential antimicrobial and antitubercular agents.
Suresh Kumar GV; Rajendraprasad Y; Mallikarjuna BP; Chandrashekar SM; Kistayya C
Eur J Med Chem; 2010 May; 45(5):2063-74. PubMed ID: 20149496
[TBL] [Abstract][Full Text] [Related]
9. Thiazole-aminopiperidine hybrid analogues: design and synthesis of novel Mycobacterium tuberculosis GyrB inhibitors.
Jeankumar VU; Renuka J; Santosh P; Soni V; Sridevi JP; Suryadevara P; Yogeeswari P; Sriram D
Eur J Med Chem; 2013; 70():143-53. PubMed ID: 24148991
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, antimycobacterial and antitumor activities of new (1,1-dioxido-3-oxo-1,2-benzisothiazol-2(3H)-yl)methyl N,N-disubstituted dithiocarbamate/O-alkyldithiocarbonate derivatives.
Güzel O; Salman A
Bioorg Med Chem; 2006 Dec; 14(23):7804-15. PubMed ID: 16931027
[TBL] [Abstract][Full Text] [Related]
11. A regio- and stereoselective 1,3-dipolar cycloaddition for the synthesis of new-fangled dispiropyrrolothiazoles as antimycobacterial agents.
Almansour AI; Ali S; Ali MA; Ismail R; Choon TS; Sellappan V; Elumalai KK; Pandian S
Bioorg Med Chem Lett; 2012 Dec; 22(24):7418-21. PubMed ID: 23122863
[TBL] [Abstract][Full Text] [Related]
12. New antitumor imidazo[2,1-b]thiazole guanylhydrazones and analogues.
Andreani A; Burnelli S; Granaiola M; Leoni A; Locatelli A; Morigi R; Rambaldi M; Varoli L; Calonghi N; Cappadone C; Farruggia G; Zini M; Stefanelli C; Masotti L; Radin NS; Shoemaker RH
J Med Chem; 2008 Feb; 51(4):809-16. PubMed ID: 18251494
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antimicrobial activity of some novel hydrazide, benzochromenone, dihydropyridine, pyrrole, thiazole and thiophene derivatives.
Refat HM; Fadda AA
Eur J Med Chem; 2013; 70():419-26. PubMed ID: 24184775
[TBL] [Abstract][Full Text] [Related]
14. (E)-2-(2-Allylidenehydrazinyl)thiazole derivatives: Design, green synthesis, in silico and in vitro antimycobacterial and radical scavenging studies.
Hublikar M; Kadu V; Dublad JK; Raut D; Shirame S; Makam P; Bhosale R
Arch Pharm (Weinheim); 2020 Jul; 353(7):e2000003. PubMed ID: 32372473
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of anti-tubercular and antibacterial activities of new 4-(2,6-dichlorobenzyloxy)phenyl thiazole, oxazole and imidazole derivatives. Part 2.
Lu X; Liu X; Wan B; Franzblau SG; Chen L; Zhou C; You Q
Eur J Med Chem; 2012 Mar; 49():164-71. PubMed ID: 22264895
[TBL] [Abstract][Full Text] [Related]
16. Natural product-based design, synthesis and biological evaluation of anthra[2,1-d]thiazole-6,11-dione derivatives from rhein as novel antitumour agents.
Liang YK; Yue ZZ; Li JX; Tan C; Miao ZH; Tan WF; Yang CH
Eur J Med Chem; 2014 Sep; 84():505-15. PubMed ID: 25050882
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antituberculosis activity of new thiazolylhydrazone derivatives.
Turan-Zitouni G; Ozdemir A; Kaplancikli ZA; Benkli K; Chevallet P; Akalin G
Eur J Med Chem; 2008 May; 43(5):981-5. PubMed ID: 17719146
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, molecular docking and evaluation of thiazolyl-pyrazoline derivatives as EGFR TK inhibitors and potential anticancer agents.
Lv PC; Li DD; Li QS; Lu X; Xiao ZP; Zhu HL
Bioorg Med Chem Lett; 2011 Sep; 21(18):5374-7. PubMed ID: 21802290
[TBL] [Abstract][Full Text] [Related]
19. A New Series of Antileukemic Agents: Design, Synthesis, In Vitro and In Silico Evaluation of Thiazole-Based ABL1 Kinase Inhibitors.
Zeytün E; Altıntop MD; Sever B; Özdemir A; Ellakwa DE; Ocak Z; Ciftci HI; Otsuka M; Fujita M; Radwan MO
Anticancer Agents Med Chem; 2021; 21(9):1099-1109. PubMed ID: 32838725
[TBL] [Abstract][Full Text] [Related]
20. One-Pot Synthesis of Novel Thiazoles as Potential Anti-Cancer Agents.
Sayed AR; Gomha SM; Taher EA; Muhammad ZA; El-Seedi HR; Gaber HM; Ahmed MM
Drug Des Devel Ther; 2020; 14():1363-1375. PubMed ID: 32308369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
